Summary
Danaher Corporation (DHR) has filed a Current Report (8-K) on January 12, 2026, providing an early look at its estimated financial performance for the fourth quarter of 2025. This release is in anticipation of the company's participation in the J.P. Morgan Healthcare Conference scheduled for January 13, 2026. While specific financial figures are not detailed within the 8-K itself, the filing incorporates by reference a press release and presentation slides that contain this estimated performance data. Investors should note that this information is furnished and not deemed "filed" under Section 18 of the Exchange Act, meaning it carries a different legal implication than a standard filing. The attached exhibits, including the press release and presentation slides, are the primary sources for understanding Danaher's preliminary Q4 2025 and full-year 2025 financial outlook. These documents are crucial for investors to assess the company's recent operational results and financial condition ahead of the J.P. Morgan conference.
Key Highlights
- 1Danaher Corporation (DHR) filed an 8-K on January 12, 2026, disclosing estimated Q4 2025 financial performance.
- 2The filing precedes Danaher's presentation at the J.P. Morgan Healthcare Conference on January 13, 2026.
- 3The press release and presentation slides containing the estimated financial performance are incorporated by reference.
- 4This filing provides an early outlook on Danaher's financial results for the fourth quarter and the full year of 2025.
- 5The information furnished is not considered "filed" for purposes of Section 18 of the Exchange Act.
- 6Exhibits include a press release titled "Danaher CEO to Comment on Financial Performance" and selected presentation slides.